Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/22/2026

Treatment of Ureteral Obstruction

Initial Management

  • For patients with sepsis and/or anuria due to obstructed kidney, urgent decompression of the collecting system is mandatory, according to the European Urology guidelines 1
  • The European Urology guidelines recommend that urine should be collected for antibiogram testing before and after decompression 1
  • Antibiotics should be given immediately and regimen adjusted following antibiogram results, as recommended by the European Urology guidelines 1
  • Intensive care may be necessary in severe cases, according to the European Urology guidelines 1

Pain Management

  • The European Urology guidelines recommend NSAIDs (diclofenac, ibuprofen, metamizole) as first-line treatment for renal colic 1
  • NSAIDs reduce the need for additional analgesia compared to opioids, according to the European Urology guidelines 1
  • The European Urology guidelines suggest using the lowest effective dose of NSAIDs to minimize cardiovascular and gastrointestinal risks 1
  • Opioids are recommended as second-choice analgesics when NSAIDs are contraindicated, according to the European Urology guidelines 1

Treatment Options

  • Medical expulsive therapy (MET) with alpha-blockers (such as tamsulosin) is effective for stones amenable to conservative management, particularly for stones >5mm in the distal ureter, as recommended by the European Urology guidelines 1
  • For uric acid stones, oral chemolysis with citrate or sodium bicarbonate (pH 7.0-7.2) can dissolve stones with a success rate of 80.5%, according to the European Urology guidelines 1
  • For obstruction due to advanced malignancies, retrograde ureteral stenting, PCN, or percutaneous antegrade ureteral stenting are all appropriate options, as recommended by the Journal of the American College of Radiology guidelines 2
  • PCN decompression as primary management of ureteral injuries results in decreased need for reoperation and decreased morbidity rates, according to the Journal of the American College of Radiology guidelines 2

Special Considerations

  • For pregnant patients with obstruction, ultrasound is strongly recommended as first-line imaging, according to the European Urology guidelines 1
  • Both retrograde ureteral stenting and PCN are appropriate for pregnant patients with flank pain, fever, and hydronephrosis, as recommended by the Journal of the American College of Radiology guidelines 3
  • Renal tuberculosis is treated primarily with medical therapy, and a 6-month regimen is recommended, according to the American Journal of Respiratory and Critical Care Medicine guidelines 4
  • If ureteral obstruction occurs, procedures to relieve the obstruction are indicated, as recommended by the American Journal of Respiratory and Critical Care Medicine guidelines 4

Management of Complications

  • Postprocedural bacteremia and sepsis are common when infected urinary tracts are drained, according to the Journal of the American College of Radiology guidelines 5
  • Preprocedural antibiotics are recommended when urosepsis is suspected or known to be present, as recommended by the Journal of the American College of Radiology guidelines 5
  • Third-generation cephalosporin ceftazidime has shown superiority over fluoroquinolone ciprofloxacin in both clinical and microbiological cure rates, according to the Journal of the American College of Radiology guidelines 5
  • PCN has been shown to improve early and long-term cure rates compared to ureteral stent in cases of infection, as recommended by the Journal of the American College of Radiology guidelines 5

Management of Complications After Ureteral Stenting

Diagnostic Considerations

  • The American College of Radiology recommends using CT scan if complications such as obstruction or perinephric stranding are suspected, especially in non-pregnant patients 6
  • In patients with severe symptoms, such as fever, flank pain, or signs of sepsis, hospitalization may be necessary for IV antibiotics and close monitoring, as per guidelines from the American College of Radiology 6
  • The American College of Radiology suggests that if symptoms are mild to moderate, oral antibiotics appropriate for urinary tract infections can be used, with close follow-up within 48-72 hours to ensure clinical improvement 6
  • Avoid delaying treatment if signs of infection are present, as urosepsis can develop rapidly, according to the American College of Radiology 6

Guidelines for Hematuria Evaluation and Stent Removal After Ureteral Stenting

Persistent Gross Hematuria

  • Persistent gross hematuria lasting more than 48–72 hours after ureteral stent placement warrants diagnostic evaluation (e.g., imaging and urine culture) because it may indicate complications such as obstruction or infection. 7

Timing and Indications for Stent Removal

  • Stents placed for indications such as ureteral injury, stricture, substantial residual stone burden, solitary kidney, or renal insufficiency should not be removed prematurely; temporary stenting is required to maintain drainage and protect renal function. 8

  • When feasible, a pull‑string (removable) stent should be considered at the time of insertion to avoid a second cystoscopic procedure for removal, thereby reducing patient discomfort and healthcare utilization. 8

Immediate Diagnostic Work‑Up and Management of Infected Obstructed Urinary Systems

Diagnostic Evaluation

  • Obtain blood cultures (minimum two sets) and urine cultures before any change in antimicrobial therapy to identify the causative pathogen and guide definitive treatment. American College of Radiology guideline. 9
  • In patients with persistent fever, leukocytosis, or clinical deterioration despite ureteral stenting, immediate escalation of antibiotic coverage is recommended while awaiting culture results. American College of Radiology guideline. 9

Imaging Recommendations

  • Perform a contrast‑enhanced CT urogram as the first‑line imaging modality to assess:

  • Do not postpone imaging when clinical status worsens; prompt CT is required to identify correctable anatomic causes such as malpositioned stents, new obstruction, or perinephric collections. American College of Radiology guideline. 9

Drainage Indications

  • Percutaneous nephrostomy (PCN) should be instituted without delay in any patient who is septic, hypotensive, or shows worsening renal function, as PCN provides superior drainage compared to internal stents in pyonephrosis and improves early and long‑term cure rates. American College of Radiology recommendation. 9

  • The American College of Radiology specifically recommends PCN for patients with a prolonged history of flank pain, fever, leukocytosis, and a dilated collecting system who appear septic. American College of Radiology recommendation. 9

  • If CT reveals any of the following:

  • In hemodynamically unstable or septic patients, PCN may be performed emergently before imaging if necessary to achieve rapid source control. American College of Radiology guideline. 9

Monitoring and Follow‑Up

  • After infection control and definitive culture results, tailor antimicrobial therapy to sensitivities and continue monitoring until temperature, white‑blood‑cell count, and inflammatory markers have returned to normal before considering stent removal or further intervention. American College of Radiology guideline. 10

Antibiotic and Follow‑up Strategies for Ureteral Stent Clot Obstruction

Antimicrobial Management

  • The American College of Radiology recommends administering pre‑procedural antibiotics when urosepsis is suspected or confirmed, to reduce infection‑related complications before stent manipulation or replacement. 11
  • According to the American College of Radiology, a third‑generation cephalosporin (ceftazidime) provides superior clinical and microbiological cure rates compared with a fluoroquinolone (ciprofloxacin) in patients undergoing ureteral stent procedures for clot obstruction. 11

Post‑procedure Imaging and Follow‑up

  • Follow‑up cystography or cross‑sectional imaging should be performed to verify complete resolution of the underlying pathology before removal of the ureteral stent, ensuring that obstruction or infection has been adequately addressed. 12

Urgent Percutaneous Nephrostomy (PCN) for Source‑Control in Septic Obstructive Uropathy

Indications & Clinical Context

  • In patients with obstructed infected urinary systems presenting with septic shock or refractory fever, immediate PCN placement provides larger‑bore drainage that is essential for rapid source control. The American College of Radiology (ACR) guideline recommends PCN as the preferred option “in a setting such as pyonephrosis, when larger tube decompression may be warranted.” [Strong recommendation] 13
  • The ACR explicitly advises PCN for patients at high risk for anesthesia or when internal stents are unlikely to achieve adequate drainage (e.g., extrinsic obstruction, heavy bacterial load). [Strong recommendation] 13

Superiority of PCN Compared with Retrograde Ureteral Stenting

  • In septic patients with obstructed infected systems, retrograde ureteral catheters (DJ stents) are associated with a higher risk of persistent urosepsis than PCN, especially when extrinsic obstruction or high bacterial burden is present. [Moderate evidence] 13
  • Comparative data cited by the ACR show that PCN improves early and long‑term cure rates relative to ureteral stents in infection‑related obstruction. [Moderate evidence] 13

Diagnostic Steps Prior to Antimicrobial Modification

  • The Surviving Sepsis Campaign (SSC) guidelines mandate obtaining at least two sets of blood cultures and a urine culture before any change in antimicrobial therapy when a patient has temperature ≥ 38 °C with systemic signs of infection. [Strong recommendation] 14, 15
  • SSC also identifies diabetes, recent major surgery, prolonged broad‑spectrum antibiotics, and indwelling urinary devices as risk factors for invasive Candida infection; therefore, early fungal coverage (e.g., an echinocandin) is recommended in such high‑risk patients. [Strong recommendation] 14, 15

Antimicrobial Strategy While Awaiting Source Control

  • Broad‑spectrum regimens that include agents active against multidrug‑resistant Gram‑negative bacteria and an echinocandin for possible Candida are appropriate pending culture results in critically ill patients with obstructive urosepsis. [Consensus] 16
  • The World Journal of Emergency Surgery (WJES) emphasizes that inadequate source control, rather than antimicrobial resistance alone, is the primary driver of persistent shock in these scenarios; therefore, securing drainage should precede any escalation of antimicrobial therapy. [Strong recommendation] 17

Post‑PCN Management

  • After successful PCN and receipt of culture data, antimicrobial therapy should be tailored to sensitivities and de‑escalated when feasible, provided source control is confirmed. [Strong recommendation] 16, 17
  • Intensive monitoring for post‑procedural bacteremia and sepsis is essential because drainage of an infected urinary system can transiently disseminate organisms. [Consensus]

Common Pitfalls to Avoid

  • Do not postpone PCN while attempting further antimicrobial escalation; delayed drainage is linked to continued shock. [Strong recommendation] 13
  • Do not assume internal stents provide adequate drainage in pyonephrosis or high bacterial load situations; failure to recognize this can lead to persistent infection. [Strong recommendation] 13
  • Do not change antibiotics before obtaining cultures, as this compromises diagnostic accuracy and may miss resistant or fungal pathogens. [Strong recommendation] 14, 15

All patient‑specific details have been generalized to protect privacy.

REFERENCES

12